Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 122.00 | |
50 mg | In stock | $ 198.00 | |
100 mg | In stock | $ 328.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor. |
Targets&IC50 | BRPF3:>10μM, BRPF2:7.9 μM, BRPF1:80 nM |
In vitro | PFI-4 is cell permeable, and acts by displacing the BRPF1 bromodomain from Histone H3.3. [1] |
Synonyms | PFI4 |
Molecular Weight | 380.44 |
Formula | C21H24N4O3 |
CAS No. | 900305-37-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 14 mg/mL (36.8 mM)
Ethanol: 5 mg/mL (13.14 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PFI-4 900305-37-5 Chromatin/Epigenetic Epigenetic Reader Domain bone loss Inhibitor inhibit osteoclasts PFI4 osteolytic malignant bone lesions PFI 4 inhibitor